Insights from 2024 ASCO® GU Annual Meeting

Videos
09:54

Insights from 2024 ASCO® GU Annual Meeting

The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors

FEATURING Rana McKay
  • 190 views
  • April 15, 2024
  • 2
09:53

Insights from 2024 ASCO® GU Annual Meeting

Real-World Genomic Testing Patterns in Patients With Prostate Cancer

FEATURING Dalia Kaakour
  • 183 views
  • March 13, 2024
  • 1
16:05

Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

FEATURING Thomas Powles, Brian Rini
  • 1,547 views
  • March 7, 2024
  • 6
05:31

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Subgroup Analyses of Efficacy Outcomes by Baseline Tumor Size in the CLEAR Trial - Lenvatinib & Pembro in 1L Treatment of aRCC"

FEATURING Viktor Grünwald
  • 88 views
  • March 5, 2024
10:56

Insights from 2024 ASCO® GU Annual Meeting

From CHAARTED Low- and High-Volume Disease to PSMA PET Imaging Volume in mHSPC

FEATURING Lena Unterrainer
  • 108 views
  • March 5, 2024
07:53

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Transperineal Versus Transrectal Prostate Biopsy to Prevent Infectious Complications - The PREVENT Randomized Trial"

FEATURING Jim Hu
  • 138 views
  • March 5, 2024
19:02

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Underutilization of ADT Intensification for the Treatment of Men With mHSPC - A Systematic Review of Real-World Database Studies"

FEATURING Peter Goebell
  • 100 views
  • March 4, 2024
04:50

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Nivo + Cabozantinib vs. Sunitinib for Previously Untreated Advanced RCC - Results From 55-Month Follow-Up of the CheckMate 9ER Trial"

FEATURING Maria Bourlon
  • 260 views
  • February 20, 2024
  • 2
07:53

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Subcutaneous vs. Intravenous Nivo for Previously Treated Advanced or Metastatic ccRCC: Pharmacokinetics, Efficacy, and Safety Results From CheckMate 67T"

FEATURING Saby George
  • 126 views
  • February 20, 2024
03:19

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Difference in High-Risk Prostate Cancer Detection Between Transrectal and Transperineal Fusion Approaches"

FEATURING Sofiya Semko
  • 141 views
  • February 20, 2024
  • 2
04:14

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Patient-Provider Rurality and Outcomes in Older Men With Prostate Cancer"

FEATURING Avirup Guha
  • 57 views
  • February 20, 2024
20:40

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Role of Systemic Therapy for Node Positive Bladder Cancer Patients After Achieving Complete Clinical Response"

FEATURING Monika Joshi
  • 162 views
  • February 20, 2024
  • 1
04:50

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Salvage RT for Local Recurrence of Prostate Cancer After RT"

FEATURING Alan Dal Pra
  • 128 views
  • February 20, 2024
16:08

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Salvage Radiotherapy Options for Biochemical Recurrence After Radical Prostatectomy"

FEATURING Alan Dal Pra
  • 87 views
  • February 20, 2024
  • 1
11:27

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "EMBARK Trial - Outcomes of Men With High-Risk Biochemically Recurrent Prostate Cancer Who Suspended Enzalutamide Monotherapy Treatment"

FEATURING Neal Shore
  • 273 views
  • February 20, 2024
  • 4
05:48

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "UNITE Study - Outcomes in Patients With Advanced Urothelial Carcinoma Treated With EV After Switch Maintenance Avelumab"

FEATURING Amanda Nizam
  • 177 views
  • February 20, 2024
  • 1
06:55

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "HER2 and PD-L1 Immunohistochemistry Expression, and HER2 Genomic Alterations - Associations and Clinical Outcomes for Advanced Bladder Cancer"

FEATURING David Aggen
  • 113 views
  • February 20, 2024
  • 1
09:03

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Long-Term Follow-Up Data From the CheckMate 214 Trial - Nivo + Ipi vs. Sunitinib for 1L Treatment of aRCC"

FEATURING David McDermott
  • 157 views
  • February 14, 2024
  • 4
12:39

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Prognostic Value of FDG, PSMA, and DOTATATE Uptake on PET Imaging in mCRPC"

FEATURING Frédéric Pouliot
  • 98 views
  • February 13, 2024
26:15

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Update on Biomarkers in Renal Cell Carcinoma"

FEATURING David Braun
  • 133 views
  • February 9, 2024
  • 2
05:31

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "PSA Flare in Patients With mCRPC Undergoing 177Lu-PSMA Treatment"

FEATURING Haoran Li
  • 55 views
  • February 9, 2024
09:59

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "PROMPT-2 Trial - PSA Response Among Patients With mCSPC Initiated on Apalutamide or Abiraterone Acetate in Real-World Urology Practices"

FEATURING Gordon Brown
  • 226 views
  • February 9, 2024
  • 1
14:16

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

FEATURING Eleni Efstathiou
  • 2,692 views
  • February 8, 2024
  • 12
03:56

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "SPOTLIGHT Study - Impact of 18F-flotufolastat PET on Management of Patients With Recurrent Prostate Cancer"

FEATURING Przemyslaw Twardowski
  • 88 views
  • February 8, 2024
  • 2
09:38

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Management of Non-ccRCC"

FEATURING Katy Beckermann
  • 90 views
  • February 8, 2024
06:05

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Differences in Genomic, Transcriptomic, and Immune Landscape of Prostate Cancer Based on Site of Metastasis"

FEATURING Umang Swami
  • 87 views
  • February 7, 2024
06:26

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Radiographic Progression Without PSA Progression in mHSPC - A Retrospective Analysis From the ENZAMET Trial"

FEATURING Ian Davis
  • 120 views
  • February 7, 2024
12:56

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Predicting Clinical Outcomes of Neoadjuvant Chemo for Localized MIBC in the S1314-COXEN Trial Using a Multimodal Deep Learning Model Integrating Histopathology, Cell Types, and Gene Expression"

FEATURING Bishoy Faltas
  • 92 views
  • February 7, 2024
05:07

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "TROPION‑PanTumor01 Study - Dato-DXd in Locally Advanced/Metastatic Urothelial Cancer"

FEATURING Alexandra Drakaki
  • 48 views
  • February 6, 2024
10:29

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "AMBASSADOR Alliance A031501 Study of Pembro in MIUC and Locally Advanced UC vs. Observation"

FEATURING Andrea Apolo
  • 167 views
  • February 6, 2024
  • 1
09:39

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "PemCab Trial - Cabozantinib + Pembro as 1L Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma"

FEATURING Rohit Jain
  • 141 views
  • February 6, 2024
06:21

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "JAVELIN Bladder 100 & US PATRIOT-II Studies - Avelumab 1L Maintenance for Advanced Urothelial Carcinoma"

FEATURING Petros Grivas
  • 76 views
  • February 6, 2024
  • 1
14:00

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Carcinoma"

FEATURING Guru Sonpavde
  • 424 views
  • February 6, 2024
  • 8
10:40

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Systemic Treatment of High-Risk Biochemically Recurrent Prostate Cancer"

FEATURING Channing Paller
  • 221 views
  • February 6, 2024
05:46

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Adherence to ASCO® Language of Respect Guidelines in ASCO® Annual Meeting Prostate Cancer Abstracts"

FEATURING Regina Barragán Carrillo
  • 57 views
  • February 6, 2024
14:51

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Tailoring Prostate Cancer Care - EMBARK Findings, QoL and Real-World Treatment Patterns for High-Risk Biochemically Recurrent Prostate Cancer & Real World Impact of Doublet Therapy in mCSPC"

FEATURING Stephen Freedland
  • 385 views
  • February 1, 2024
  • 2
11:21

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "CABATEN/GETNE-T1914 Trial - Cabo + Atezo in Locally Advanced/Metastatic Adrenocortical Carcinoma"

FEATURING Enrique Grande
  • 66 views
  • February 1, 2024
  • 1
04:43

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Real-World Comparison of PSA Response in Patients With mCSPC Treated With Apalutamide or Enzalutamide"

FEATURING Benjamin Lowentritt
  • 266 views
  • February 1, 2024
07:26

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Impact of Standard-of-Truth Method on Evaluation of a Diagnostic PET Radiopharmaceutical in Prostate Cancer - Learnings From the SPOTLIGHT Study"

FEATURING Benjamin Lowentritt
  • 72 views
  • February 1, 2024